Top Undervalued Drug Manufacturers - Specialty & Generic industry Stocks 2026

Elanco Animal Health (ELAN) is the most undervalued stock in the Drug Manufacturers - Specialty & Generic industry with an estimated 17.8% upside.

Updated todayBased on intrinsic value modelsIndustry: Drug Manufacturers - Specialty & Generic

Page snapshot: 26 July 2026, 10:09 pm

View full analysis in the screener → · All undervalued →

Before you trade on valuation alone

Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.

Drug Manufacturers - Specialty & Generic Industry Valuation Insights (Updated Today)

  • The Drug Manufacturers - Specialty & Generic industry currently shows an average upside of 17.8% on this snapshot.
  • Top name Elanco Animal Health Incorporated (ELAN) trades at roughly a 17.8% discount to modeled intrinsic value—rankings move with prices and inputs.
  • This industry's average upside is below our broad undervalued benchmark (~27.7%).

Undervalued Drug Manufacturers - Specialty & Generic Stocks by Market Cap

Large cap (top 5)

  1. 1.Elanco Animal Health Incorporated · ELAN17.8%$12.44B

Mid cap (top 5)

No qualifying names in this bucket on this snapshot.

Small cap (top 5)

No qualifying names in this bucket on this snapshot.

What Are Undervalued Drug Manufacturers - Specialty & Generic Stocks?

Undervalued drug manufacturers - specialty & generic stocks are names where price sits below modeled fair (intrinsic) value—often expressed as positive headline upside versus the current quote.

This is not a buy list. Validate each symbol on its company page before you act.

How We Identify Undervalued Drug Manufacturers - Specialty & Generic Stocks

We pull an industry-filtered undervalued snapshot (price, intrinsic value, upside, cap, sector, country) and rank by headline upside. You can sort and search in the table above.

Rankings can shift intraday as prices and model inputs move. Use the stock screener for custom filters beyond this industry leaderboard.

FAQs

Answers about undervalued drug manufacturers - specialty & generic names, intrinsic value, and how often this list refreshes.

What are undervalued drug manufacturers - specialty & generic stocks?

They are Drug Manufacturers - Specialty & Generic names trading below modeled intrinsic value—shown here as upside % versus price. Models vary; use this as a screen, not advice.

How do you find undervalued drug manufacturers - specialty & generic stocks?

We load undervalued names for this industry from our API, then rank and filter in the table. Sort columns and open company pages to dig deeper.

Why are drug manufacturers - specialty & generic stocks undervalued?

Often sentiment, earnings, cycles, rates, or stock-specific news—not always a “misprice.” Intrinsic value is model-dependent.

Are undervalued drug manufacturers - specialty & generic stocks a good investment?

Not by label alone. Discounts can reflect risk or data lag. Check fundamentals and your goals; seek professional advice if needed.

How often is this list updated?

The page rebuilds on a schedule (ISR). Live quotes can move faster—use company pages for the latest.

Data updated regularly. Intrinsic value estimates and stock prices are subject to market fluctuations.